BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24325456)

  • 1. Immunoadjuvant efficacy of N-carboxymethyl chitosan for vaccination via dendritic cell activation.
    Kim JJ; Nam JP; Nah JW; Jang MK; Yee ST
    J Med Food; 2014 Feb; 17(2):268-77. PubMed ID: 24325456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
    Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
    Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
    Slütter B; Jiskoot W
    J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corynebacterium pyruviciproducens promotes the production of ovalbumin specific antibody via stimulating dendritic cell differentiation and up-regulating Th2 biased immune response.
    Qingzhen H; Jia T; Shengjun W; Yang Z; Yanfang L; Pei S; Essien BS; Zhaoliang S; Sheng X; Qixiang S; Finegold SM; Xu H
    Vaccine; 2012 Feb; 30(6):1115-23. PubMed ID: 22178104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
    Wei J; Xue W; Yu X; Qiu X; Liu Z
    J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.
    Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN
    J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
    Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
    J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
    Saint-Lu N; Tourdot S; Razafindratsita A; Mascarell L; Berjont N; Chabre H; Louise A; Van Overtvelt L; Moingeon P
    Allergy; 2009 Jul; 64(7):1003-13. PubMed ID: 19220212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol mannosides are efficient mucosal adjuvants.
    Parlane NA; Denis M; Severn WB; Skinner MA; Painter GF; La Flamme AC; Ainge GD; Larsen DS; Buddle BM
    Immunol Invest; 2008; 37(2):129-42. PubMed ID: 18300038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.
    Huang H; Ostroff GR; Lee CK; Specht CA; Levitz SM
    mBio; 2010 Jul; 1(3):. PubMed ID: 20802824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination.
    Mittal A; Schulze K; Ebensen T; Weissmann S; Hansen S; Guzmán CA; Lehr CM
    J Control Release; 2015 May; 206():140-52. PubMed ID: 25795506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells.
    Lemoine S; Jaron B; Tabka S; Ettreiki C; Deriaud E; Zhivaki D; Le Ray C; Launay O; Majlessi L; Tissieres P; Leclerc C; Lo-Man R
    J Allergy Clin Immunol; 2015 Nov; 136(5):1355-68.e1-15. PubMed ID: 25865351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
    Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice.
    Shibuya K; Robinson D; Zonin F; Hartley SB; Macatonia SE; Somoza C; Hunter CA; Murphy KM; O'Garra A
    J Immunol; 1998 Feb; 160(4):1708-16. PubMed ID: 9469428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg1 Activates Dendritic Cells and Acts as a Vaccine Adjuvant Inducing Protective Cellular Responses Against Lymphomas.
    Huang Y; Zou Y; Lin L; Zheng R
    DNA Cell Biol; 2017 Dec; 36(12):1168-1177. PubMed ID: 29058460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
    Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.